Examiner With Narrow Scope Approved In Purdue Ch. 11

Law360 (June 16, 2021, 6:44 p.m. EDT) – A New York bankruptcy judge reluctantly approved the appointment of an examiner in the Chapter 11 case of OxyContin maker Purdue Pharma LP on Wednesday, saying he did not did so only because the unfounded allegations included in the Examiner’s Request had to be dealt with publicly.

In a hearing conducted by videoconference and telephone, U.S. bankruptcy judge Robert Drain castigated documents filed by Professor Jonathan C. Lipson of Temple University’s Beasley School of Law on behalf of creditor Peter Jackson to request the appointment of an examiner. Justice Drain concluded that Lipson’s papers were used to deceive the thousands of people involved in …

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
  • Create personalized alerts for specific case articles and topics and more!

TRY LAW360 FREE FOR SEVEN DAYS

Comments are closed.